Medicare services provided by cardiologists in the United States: 1999-2008

Bruce W Andrus1, H Gilbert Welch

  • 1Section of Cardiology, Heart and Vascular Center, Dartmouth-Hitchcock Medical Center, Lebanon, NH 03756, USA. bruce.w.andrus@dartmouth.edu

Insights

Cardiologist services grew 44% from 1999-2008, driven by a 70% increase in noninvasive imaging procedures. This trend significantly impacted Medicare spending on cardiology.

Area of Science:

  • Cardiovascular Medicine
  • Health Services Research
  • Medical Economics

Background:

  • Cardiology services constitute a significant portion of Medicare specialist physician expenditures.
  • The growth and distribution patterns of these services over the last decade remain underexplored.

Purpose of the Study:

  • To describe the absolute growth and distribution of services provided by cardiologists between 1999 and 2008.
  • To identify the specific service categories contributing most to the observed changes in cardiology practice.

Main Methods:

  • Analysis of fee-for-service Medicare Part B claims from 1999-2008.
  • Categorization of approximately 1000 CPT-9 codes into 45 service groups, further aggregated into evaluation/management, noninvasive, and invasive procedures.
  • Calculation of services and allowed charges per 1000 beneficiaries.

Main Results:

  • Claims from cardiologists increased by 44% (2082-2997 per 1000 beneficiaries) from 1999-2008.
  • Allowed charges, adjusted for inflation, rose by 28% ($181,397-231,728 per 1000 beneficiaries).
  • Noninvasive procedures, particularly resting echocardiograms and nuclear stress tests, drove most of this growth, with a 70% increase in claims.

Conclusions:

  • The primary driver of increased cardiology services over the past decade has been the expanded use of noninvasive imaging techniques.
  • This shift has significant implications for Medicare spending and healthcare resource allocation in cardiology.
Abstract

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However, frequent irregular...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...